These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38276545)

  • 1. Identification and Characterization of Neuroprotective Properties of Thaumatin-like Protein 1a from
    D'Errico A; Nasso R; Di Maro A; Landi N; Chambery A; Russo R; D'Angelo S; Masullo M; Arcone R
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38276545
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Nasso R; Pagliara V; D'Angelo S; Rullo R; Masullo M; Arcone R
    Pharmaceuticals (Basel); 2021 Jan; 14(1):. PubMed ID: 33466604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Enzymes Involved in Neurodegenerative Disorders and A
    Arcone R; D'Errico A; Nasso R; Rullo R; Poli A; Di Donato P; Masullo M
    Molecules; 2023 Aug; 28(17):. PubMed ID: 37687161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and Aβ
    Plazas E; Hagenow S; Avila Murillo M; Stark H; Cuca LE
    Bioorg Chem; 2020 May; 98():103722. PubMed ID: 32155491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
    Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S
    Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease.
    Zheng H; Amit T; Bar-Am O; Fridkin M; Youdim MB; Mandel SA
    J Alzheimers Dis; 2012; 30(1):1-16. PubMed ID: 22387411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-activated multi target iron chelators with acetylcholinesterase (AChE) and monoamine oxidase (MAO) inhibitory activities for Alzheimer's disease therapy.
    Youdim MBH
    J Neural Transm (Vienna); 2022 Jun; 129(5-6):715-721. PubMed ID: 35190910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
    Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
    ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and in vitro evaluation of 4-aminoalkyl-1(2H)-phthalazinones as potential multifunctional anti-Alzheimer's disease agents.
    Ye C; Xu R; Cao Z; Song Q; Yu G; Shi Y; Liu Z; Liu X; Deng Y
    Bioorg Chem; 2021 Jun; 111():104895. PubMed ID: 33887586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multitarget 2'-hydroxychalcones as potential drugs for the treatment of neurodegenerative disorders and their comorbidities.
    Kamecki F; Knez D; Carvalho D; Marcucci C; Rademacher M; Higgs J; Žakelj S; Marcos A; de Tezanos Pinto F; Abin-Carriquiry JA; Gobec S; Colettis N; Marder M
    Neuropharmacology; 2021 Dec; 201():108837. PubMed ID: 34653442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro and In Vivo Investigations of Chromone Derivatives as Potential Multitarget-Directed Ligands: Cognitive Amelioration Utilizing a Scopolamine-Induced Zebrafish Model.
    Kumar N; Jangid K; Kumar V; Yadav RP; Mishra J; Upadhayay S; Kumar V; Devi B; Kumar V; Dwivedi AR; Kumar P; Baranwal S; Bhatti JS; Kumar V
    ACS Chem Neurosci; 2024 Jul; 15(14):2565-2585. PubMed ID: 38795037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer's disease: Design, synthesis and biological evaluation.
    Tian C; Qiang X; Song Q; Cao Z; Ye C; He Y; Deng Y; Zhang L
    Bioorg Chem; 2020 Jan; 94():103477. PubMed ID: 31818478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
    Xu R; Xiao G; Li Y; Liu H; Song Q; Zhang X; Yang Z; Zheng Y; Tan Z; Deng Y
    Bioorg Med Chem; 2018 May; 26(8):1885-1895. PubMed ID: 29500132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer's disease.
    Sang Z; Song Q; Cao Z; Deng Y; Zhang L
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):69-85. PubMed ID: 34894968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer's Disease.
    Campora M; Canale C; Gatta E; Tasso B; Laurini E; Relini A; Pricl S; Catto M; Tonelli M
    ACS Chem Neurosci; 2021 Feb; 12(3):447-461. PubMed ID: 33428389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Shi J; Liu W; Tan Z
    Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases.
    Mathew B; Parambi DGT; Mathew GE; Uddin MS; Inasu ST; Kim H; Marathakam A; Unnikrishnan MK; Carradori S
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900177. PubMed ID: 31478569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scouting around 1,2,3,4-Tetrahydrochromeno[3,2-c]pyridin-10-ones for Single- and Multitarget Ligands Directed towards Relevant Alzheimer's Targets.
    Purgatorio R; Kulikova LN; Pisani L; Catto M; de Candia M; Carrieri A; Cellamare S; De Palma A; Beloglazkin AA; Reza Raesi G; Voskressensky LG; Altomare CD
    ChemMedChem; 2020 Oct; 15(20):1947-1955. PubMed ID: 32716595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolinic Carboxylic Acid Derivatives as Potential Multi-target Compounds for Neurodegeneration: Monoamine Oxidase and Cholinesterase Inhibition.
    Khan NA; Khan I; Abid SMA; Zaib S; Ibrar A; Andleeb H; Hameed S; Iqbal J
    Med Chem; 2018; 14(1):74-85. PubMed ID: 28545383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.